CN108013170A - Double golden tea of benevolence profit - Google Patents
Double golden tea of benevolence profit Download PDFInfo
- Publication number
- CN108013170A CN108013170A CN201610932188.2A CN201610932188A CN108013170A CN 108013170 A CN108013170 A CN 108013170A CN 201610932188 A CN201610932188 A CN 201610932188A CN 108013170 A CN108013170 A CN 108013170A
- Authority
- CN
- China
- Prior art keywords
- tea
- cough
- vitamin
- benevolence
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 82
- 235000013616 tea Nutrition 0.000 claims abstract description 69
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 42
- 210000000582 semen Anatomy 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 21
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 20
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- 235000020234 walnut Nutrition 0.000 claims abstract description 20
- 235000004347 Perilla Nutrition 0.000 claims abstract description 18
- 235000009569 green tea Nutrition 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims abstract description 13
- 235000019640 taste Nutrition 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 240000007049 Juglans regia Species 0.000 claims abstract 6
- 244000124853 Perilla frutescens Species 0.000 claims abstract 6
- 241000208340 Araliaceae Species 0.000 claims abstract 5
- 206010011224 Cough Diseases 0.000 abstract description 37
- 210000004072 lung Anatomy 0.000 abstract description 29
- 208000006673 asthma Diseases 0.000 abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 201000010099 disease Diseases 0.000 abstract description 17
- 230000035622 drinking Effects 0.000 abstract description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 7
- 235000008216 herbs Nutrition 0.000 abstract description 7
- 230000010354 integration Effects 0.000 abstract description 7
- 208000026435 phlegm Diseases 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 5
- 230000001088 anti-asthma Effects 0.000 abstract description 4
- 230000000306 recurrent effect Effects 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 238000004458 analytical method Methods 0.000 abstract description 3
- 230000008859 change Effects 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 208000033065 inborn errors of immunity Diseases 0.000 abstract description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 239000003814 drug Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 17
- 240000005373 Panax quinquefolius Species 0.000 description 16
- 241000758789 Juglans Species 0.000 description 14
- 230000036541 health Effects 0.000 description 14
- 241000229722 Perilla <angiosperm> Species 0.000 description 12
- 229940079593 drug Drugs 0.000 description 8
- 239000007789 gas Substances 0.000 description 6
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 5
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 5
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 4
- LIKYNOPXHGPMIH-UHFFFAOYSA-N Dillapiole Chemical compound C=CCC1=C(OC)C(OC)=C2OCOC2=C1 LIKYNOPXHGPMIH-UHFFFAOYSA-N 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 3
- 235000011437 Amygdalus communis Nutrition 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010044302 Tracheitis Diseases 0.000 description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000003580 lung surfactant Substances 0.000 description 3
- NNICRUQPODTGRU-UHFFFAOYSA-N mandelonitrile Chemical compound N#CC(O)C1=CC=CC=C1 NNICRUQPODTGRU-UHFFFAOYSA-N 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 3
- 235000016831 stigmasterol Nutrition 0.000 description 3
- 229940032091 stigmasterol Drugs 0.000 description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ZKSZEJFBGODIJW-GMDXDWKASA-N (R)-prunasin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H](C#N)C1=CC=CC=C1 ZKSZEJFBGODIJW-GMDXDWKASA-N 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- LKZDFKLGDGSGEO-UHFFFAOYSA-N 2',8-Di-Me ether,7-O-beta-D-glucuronoside-2',5,7,8-Tetrahydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)OC(CO)C(O)C1O LKZDFKLGDGSGEO-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- LIKQBKAAXQVRGO-UHFFFAOYSA-N Panasenoside Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)ccc3C4=CC(=O)c5c(O)cc(O)cc5O4)C(O)C(O)C1O LIKQBKAAXQVRGO-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 208000010378 Pulmonary Embolism Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000004211 dillapiole Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- -1 ester sterol Chemical class 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- LKZDFKLGDGSGEO-PABQPRPFSA-N kaempferol 3-O-beta-D-glucosylgalactoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O[C@H](CO)[C@H](O)[C@@H]1O LKZDFKLGDGSGEO-PABQPRPFSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 229940043353 maltol Drugs 0.000 description 2
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- ZKSZEJFBGODIJW-UHFFFAOYSA-N passiedulin Natural products OC1C(O)C(O)C(CO)OC1OC(C#N)C1=CC=CC=C1 ZKSZEJFBGODIJW-UHFFFAOYSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- BMXNUTUYWQWEFA-UHFFFAOYSA-N prunasin Natural products OCC1OC(O)C(O)C(O)C1OC(C#N)c2ccccc2 BMXNUTUYWQWEFA-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000867477 Amara Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- XFLVBMBRLSCJAI-UHFFFAOYSA-N biotin amide Natural products N1C(=O)NC2C(CCCCC(=O)N)SCC21 XFLVBMBRLSCJAI-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002729 menthone derivatives Chemical class 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention gives a kind of double golden tea of benevolence profit, it is made of ginseng (artificial growth), walnut kernel, semen armeniacae amarae, perilla leaf, green tea, vitamin C, totally 5 taste natural plants and vitamin C.The value range of various composition：Weight ginseng (artificial growth) 0.701g 0.949g, walnut kernel 0.701g 0.949g, semen armeniacae amarae 0.701g 0.949g, perilla leaf 0.701g 0.949g, green tea 1.403g 1.898g, the vitamin C 0.043g 0.058g of the various composition of one bag of (5g) tea.Double benevolence moisten the dispensing of golden tea according to the rule of curing the disease of the traditional Chinese medical science " diagnosis and treatment based on an overall analysis of the illness and the patient's condition, reinvigoration ", fundamentally improve symptom, supplement vigour, strengthen itself resistance, coordinate at the same time and selected semen armeniacae amarae, warming lung and reducing phlegm walnut kernel, the perilla leaf of ventilating the lung and relieving cough with cough-relieving anti-asthmatic action, the natural plants of four kinds of integration of drinking and medicinal herbs of the above are with that after the exquisite compatibility of green tea, can be effectively improved cough and asthma symptom, and can gradually change situation of the cough and asthma person due to the easy recurrent exerbation of physically weak hypoimmunity.
Description
Technical field
The present invention based on the integration of drinking and medicinal herbs of traditional Chinese medicine health, particularly it is a kind of cough and asthma is significantly improved rush
Alveolitoid drink, is a kind of seasoning tea bag by the meticulous compatibility of natural plants.
Background technology
It is tea bag to season tea bag, is a kind of to carry and brew in daily life the tea-drinking drunk easy to people.
Cough and asthma is the clinical typical specific manifestation of tracheitis, as long as flu is easy for recurring, some cough and asthmas also have with allergy
Relation, the easy recurrent exerbation of cough and asthma, currently without the specific drug thoroughly cured, can finally cause chronic bronchitis, asthma, lung qi
The severe chronic disease such as swollen.The medicine of cough and asthma illness is being treated mainly with Western medicine oral capsule, tablet and syrup, mouth at present
Based on chamber spray, opiates (morphine or codeine) additive component, the compound of Ma Yinglong medicine companies group production are typically contained
Contain morphine in radix glycyrrhizae oral administration solution component, although this similar drug has obvious antitussive action, easy habituation, later stage clothes
Used in amounts continues to increase the effect of just having；Chinese patent drug pectoral to strengthen the body resistance to consolidate the constitution, it is clearing heat and detoxicating based on, medicine by oral administration after, medicine
Effect effect is slow, Chinese ephedra alkali composition can be contained in indivedual Chinese patent drugs, cough-relieving Zhichuan effect is preferable, but can stimulate central nervous system
System, patient may occur in which the symptom such as nervous, excited or drowsiness；The common spray of asthma generally all contains hormonal substance, for a long time
Suction easily causes human body pathological, and skin wound repair occurs more, and patient is difficult to continue application.
The drinks such as the present existing " Luohan " fruit tea in market, honeysuckle tea, chrysanthemum tea be single plant extracting solution with it is pure
Water purification is mixed, and mouthfeel is sweet, both effectiveness weak.
Technical solution
The technical problem to be solved in the present invention is：Fundamentally solve the problems, such as cough and asthma crowd, (traditional Chinese medicine is supported by tea therapy
A kind of form of dietotherapy in life) mode, make people in daily drink tea away from cough and asthma.
The present invention the content of the invention be：It is by ginseng (artificial growth), walnut kernel, semen armeniacae amarae, perilla leaf, green tea, dimension
Element C is given birth to, totally 5 taste natural plants and vitamin C.The natural plants of all dispensings of the present invention, select the select quality in original producton location.Its
In the optimum weight of various composition of the golden tea of one bag (5g) double benevolence profit be：Ginseng (artificial growth) 0.825g, walnut kernel 0.825g,
Semen armeniacae amarae 0.825g, perilla leaf 0.825g, green tea 1.65g, vitamin C 0.05g, the value range of various composition can control
In optimum weight ± 15%, i.e. ginseng (artificial growth) 0.701g-0.949g, walnut kernel 0.701g-0.949g, semen armeniacae amarae
0.701g-0.949g, perilla leaf 0.701g-0.949g, green tea 1.403g-1.898g, vitamin C 0.043g-0.058g.
Each taste component content of one, this formula：
Ginseng (artificial growth)：Main component be panaxoside Ginsenoside)-RX (may separate out more than 30 to plant), have
Machine acid and esters, vitamins (vitamin B1, vitamin B2, vitamin B12, vitamin C；Nicotinic acid, folic acid, pantothenic acid, biotin
And nicotinic acid amide), sterol and its glucoside (cupreol, stigmasterol, Daucosterol, campesterol, panaxoside and ester sterol), people
Ginseng still contains：Conversion of Adenosine enzyme, L-Aspartic acid enzyme, beta amylase, invertase；Maltol (Maltol), nonacosane
(Nonacosane)；Kaempferol (Kaempferol), panasenoside (Panasenoside) and copper, zinc, iron, manganese etc. more than 20
Kind trace element.Optimum content accounts for the 16.5% of every bag of (5g) total amount.
Walnut kernel：Containing crude protein 22.18%, the wherein composition of soluble protein is secondly arginine based on glutamic acid
And aspartic acid.Thick lipid 64.23%, wherein neutral lipid account for 93.05%；Triacylglycerol 82.05% in neutral lipid, sterol
Fat 3.86%, aliphatic acid composition is mainly sub- acid 64.48%-69.95% in the total fat of free fatty 4.80%. and neutral lipid
With oleic acid 13.89%-15.36%；Triacylglycerol institute fatty acids are mainly leukotrienes 69.98；Sterol ester non-saponified portions master
To be cupreol, and have a small amount of campesterol, stigmasterol, oat steroid -5- enols, beans steroid -7- dilute alcohols；Carbohydrate 13%；It is more
The free essential amino acid of kind；Isoleucine, leucine, tryptophan, phenylalanine, valine, threonine and lysine etc., its
Content is the 47.50% of total amino acid.Optimum content accounts for the 16.5% of every bag of (5g) total amount.
Semen armeniacae amarae：Containing amarogentin (Amy-gdalin), emulsin (Amygdalase) of the amarogentin in by almond
With the hydrolysis of the beta-glucosidase such as prunase (Prunase), prunasin (Prunasin) and benzaldehyde cyanohydrin are sequentially generated
(Mandelonitrile), then to decompose generation benzaldehyde and hydrogen cyanide semen armeniacae amaraes fatty oily (apricot kernel oil) be 50.1%, and is contained
There are protein and amino acid.Optimum content accounts for the 16.5% of every bag of (5g) total amount.
Perilla leaf：Containing volatile oil about 0.5%, perillaldehyde (Pe-rillaldehyde) about 55%, left-handed limonene 20 are included
~30% and australene it is a small amount of.Also containing arginine, cumfrey, Cyanidin, perillaldehyde 16.8%-22.6%, (R)-4-isopropenyl-1-methyl-1-cyclohexene, ι-virtue
Camphor tree alcohol 3.2%-4.6%, amphene, menthol, menthones 4.2%-20%, perilla alcohol (Perillaalcohol), dihydro purple perilla
Awake 7.4%-8.5%, Eugenol etc..Optimum content accounts for the 33% of every bag of (5g) total amount.
Vitamin C：Vitamin C (Vitamin C, Ascorbic Acid) is called L-AA, is a kind of water soluble vitamin
Raw element.Vitamin C in food is absorbed by human small intestine's epimere.Once absorbing, water-soluble structures all in vivo is just distributed to
In, 1500mg vitamin Cs are there are about in the vitamin C metabolic activity pond in normal adult's body, highest stores peak value and tieed up for 3000mg
Raw element C；And have effects that oxidation resistant, other antioxidants can be protected.Optimum content accounts for the 1% of every bag of (5g) weight.
The effect of two, theories of traditional Chinese medical science foundation and each taste component：
Tea, for thousands of years, up to the kinsman of the emperor, down toward the common people, shows special preference to tea.Tea, is found by the mankind earliest
And neither drink when using, nor gift, but the medicine cured the disease.Li Shizhen (1518-1593 A.D.) exists《Compendium of Materia Medica》It is upper on the books：" all medicines
For the medicine of each disease, tea is the medicine of ten thousand diseases ".The Tang Dynasty Liu Zhenliang also once concluded that tea had ten morals：With tea gloom-dispelling, driven and slept with tea
Gas, with tea health gas, pathogenic QI in the body is removed with tea, with tea Li Liren, with tea table respect, tastes flavour with tea, is taken care of health body with tea, feasible with tea
Road, will can be supported with tea.It can be seen from the above that with tea therapy body and mind, health is enjoyed in the health that can not only cure the disease, moreover it is possible to taste product life of sampling tea.
Cough and asthma is the clinical typical specific manifestation of tracheitis, and the traditional Chinese medical science thinks this sick generation, mainly due to unsmoothness of pulmonary qi
Caused by superinverse.《Plain Questions the five internal organs generate a piece》Say：" vital organs of the human body all make us cough, not only lung "；0 says：" the lung being the dominator of QI ", lung
Gas warm four limbs bones of the body collectively and can maintain the normal physiological function activity of body completely, and insufficiency of lung-QI,deficiency of lung-QI is then physically weak, can entire body is weak and body
Body is damaged, and inducible most common illness is chronic bronchitis, or even the malignant disease such as pulmonary emphysema, pulmonary embolism, lung cancer.
The dispensing of double golden tea of benevolence profit fundamentally improves disease according to the rule of curing the disease of the traditional Chinese medical science " diagnosis and treatment based on an overall analysis of the illness and the patient's condition, reinvigoration "
Shape.Ginseng this people that the present invention selects in dispensing are referred to as " kings of hundred grass ",《Sheng Nong's herbal classic》Record：Ginseng, which has, " to be mended
The five internal organs, soothe the nerves, determine soul, stop palpitate with fear, remove pathogenic factor, happy intelligence development tomorrow " the effect of, " long term usage make light of one's life by commiting suicide macrobiosis " is to consolidate training
Member, the top grade for improving immunity of organisms, fundamentally supplement vigour, strengthen itself resistance, while coordinate and selected with only
The semen armeniacae amarae of cough anti-asthmatic action, warming lung and reducing phlegm walnut kernel, the perilla leaf of ventilating the lung and relieving cough, the natural plant of four kinds of integration of drinking and medicinal herbs of the above
Thing is with that after the exquisite compatibility of green tea, can be effectively improved cough and asthma symptom, and can gradually change cough and asthma person since physically weak hypoimmunity is easy
The situation of recurrent exerbation.
Lung governing qi, lung qi foot just can life it is vigorous, have the function that to adjust internal each internal organs device functional activity, integration of drinking and medicinal herbs
Draft quintessence by daily drinking, cough-relieving facilitaing lung, to play expected purpose.
Ginseng (artificial growth)：Reinforce vital energy, prevent prolapse and engender liquid, calms the nerves.With in tonifying Qi benefit, strengthen the body resistance to consolidate the constitution, improve it is immune
Power etc. acts on, and controls that internal lesion caused by overexertion is deficient, the card of all qi-blood-body fluid deficiencies, and the panaxoside and panaxan contained by ginseng are bodies
The active ingredient of immune function is adjusted, has and improves immunity function；Panaxan is the polymeric acidic purified in ginseng
Polysaccharide, is a kind of immunopotentiator, is observed by zoopery and human clinical trial, it was demonstrated that can significantly increase human immunity
Power.
Walnut kernel：It is warm-natured, sweet in flavor, nontoxic, there is stomach invigorating, enrich blood, moistening lung, repose and other effects.With benefiting qi and nourishing blood, warm lung
Phlegm, controls the cold of insufficiency type effect of breathing with cough etc.,《Sheng Nong's herbal classic》Walnut is classified as long term usage to make light of one's life by commiting suicide QI invigorating, the top grade promoted longevity.The Tang Dynasty Meng
Numerous writes《Dietetic materia medica》Middle description, eating walnut kernel can whet the appetite, and lead to profit blood vessels, make bone and flesh fine and smooth.Ming Dynasty's Li Shizhen writes《Herbal guiding principle
Mesh》Describe, walnut kernel has that " benefiting qi and nourishing blood, moistening dryness and resolving phlegm, the beneficial gate of vitality, place three is burnt, and warm lung ease constipation, controls the cold of insufficiency type and breath with cough, waist foot weight
Pain, trusted subordinate's colic, bloody flux intestines wind " and other effects.
Semen armeniacae amarae：With antitussive and antiasthmatic, anti-inflammatory, analgesia, the suppression effect such as mattress, prominent effect surely belongs to relieving cough and asthma, therefore quilt
It is described as " key medicine for controlling cough and asthma ".Amarogentin contained therein in vivo can be by enteric microorganism enzyme or semen armeniacae amarae contained sweet tea apricot in itself
The emulsin hydrolysis of benevolence, produces micro hydrogen cyanide and benzaldehyde, has inhibitory action to respiratory center, reach antibechic, relieving asthma
Effect.《Book on Chinese herbal medicine is looked for the truth》Record " almond, the energy of existing expelling cold, eliminating, there is the power that lower gas removes asthma again ".It is apt to relieving cough and reducing sputum and relievings asthma,
Chief complaint cough, abundant expectoration to lung system, pant and have strong specific aim, therefore doctor makes as the medication of lung system at all times
With using the experiment of guinea pig in vitro organ, almond water extracting solution can reduce the sensitiveness that organ irritates ammonium hydroxide, to antihistamine, second
The excitation of phatidylcholine, barium chloride to tracheal smooth muscle, has obvious antitussive action.Cough method is caused to prove using SO2, to small
After mouse gavage amarogentin 1mg/kg, 10mg/kg, 100mg/kg keep 30min, its inhibiting rate to frequency of coughing is respectively
26%th, 22.8%, 25.3%.The effect of gavage Semen Armeniacae Amarum extract 48.3mg/kg is stronger than equivalent amarogentin by 39.7%.Bitter apricot
For benevolence because being conducive to pulmonary respiratory function promoting the synthesis of pulmonary surfactant (PS), semen armeniacae amarae can not only promote the conjunction of PS
Into, and the various physiology in relation to lung and biochemical indicator (total phospholipids in such as lung homogenate, edema with the lung involved amount, bronchial lavage can be improved
And pathological section etc.).
Perilla leaf：With expelling cold and relieving exterior syndrome, ventilating the lung and relieving cough, qi-regulating and medium effect.The perillaldehyde isolated from perilla leaf,
Stigmasterol, Dill apiole have sedation, can extend the length of one's sleep of the rat of phenobarbital reduction, wherein
Effective dose 50=1.57mg/kg of Dill apiole, with semen armeniacae amarae at the same time use can facilitaing lung cold dispelling, preventing phlegm from forming and stopping coughing.
Each biostearin and tea polyphenols being rich in green tea, tea polyphenols are the general names of Polyphenols of Tea, are natural
Polyphenoils, have an obvious action to repairing damaged cell and improving human body immunocompetence, tealeaves not only have refreshes oneself it is clear
The heart, clearing away summerheat, eliminate indigestion and phlegm, fat-reducing slimming, relieving restlessness that clears away heart-fire, removing toxic substances sober up, promote the production of body fluid to quench thirst, fall fire improving eyesight, stop dysentery dehumidifying etc.
Pharmacological action, also to modern diseases, such as Radiation sickness, cardiovascular and cerebrovascular diseases, cancer disease, there is certain pharmacological effect.
Vitamin C is referred to as the king of vitamin, disease preventing and treating can not only be helped to help to slow down aging, and have
Extremely strong antioxidation, is normally used as nutrition fortifier in food production and antioxidant uses, and adds in the present invention
Vitamin C is added to can be used as anti-oxidant use, it is therefore intended that to prevent walnut kernel and semen armeniacae amarae in sales process because storage
There is exception in peroxide value caused by improper, to ensure the security of food, and can supplement the daily required vitamin of human body
C。
Three, prepare production technology：
The present invention with walnut kernel, semen armeniacae amarae, perilla leaf, ginseng (artificial growth) for primary raw material, through picking, cleaning, drying
Do, be ground into after 10 mesh mixed with superfine green tea, vitamin C, packing, double golden tea (seasoning tea bag) of benevolence profit made of packaging.
Advantages of the present invention：
Li Shizhen (1518-1593 A.D.) exists《Compendium of Materia Medica》It is upper on the books：" all medicines are the medicine of each disease, and tea is the medicine of ten thousand diseases ".The Tang Dynasty Liu Zhenliang
Once concluded, tea there are ten morals：With tea gloom-dispelling, driven with tea and sleep gas, with tea health gas, pathogenic QI in the body is removed with tea, with tea Li Liren, with
Tea table respect, tastes flavour with tea, is taken care of health body with tea, with tea can trade, will can be supported with tea.It can be seen from the above that with tea therapy body and mind, not only
Health is enjoyed in the health that can cure the disease, moreover it is possible to taste product life of sampling tea.
The golden tea of double benevolence profit based on the tea therapy in motherland's Chinese Traditional Medicine culture of health preserving, excavate tea sage Lu Yu tea therapy it
Marrow, according to four rules of traditional Chinese medicine health " culture life, prevention disease, ensure health, strive for longevity ", with " medicine food is same
The natural plants in source " are raw material, and combine Chinese medicine and tealeaves concocting method, it has been provided simultaneously with the treatment health effect of Chinese medicine
With " shape, color, aroma and skill " of tealeaves, have the advantages that actual effect, security, enjoying and convenience four are big, form " draft essence
The brand-new opinion of extraction, health tea therapy ".
Cough and asthma is the clinical typical specific manifestation of tracheitis, and the traditional Chinese medical science thinks this sick generation, mainly due to unsmoothness of pulmonary qi
Caused by superinverse.《Plain Questions the five internal organs generate a piece》Say：" vital organs of the human body all make us cough, not only lung "；And say：" the lung being the dominator of QI ",
Lung qi can warm four limbs bones of the body collectively and maintain the normal physiological function activity of body, insufficiency of lung-QI,deficiency of lung-QI is then physically weak, can entire body it is weak and
Body damage, inducible most common illness are chronic bronchitis, or even the malignant disease such as pulmonary emphysema, pulmonary embolism, lung cancer.
The dispensing of double golden tea of benevolence profit fundamentally improves disease according to the rule of curing the disease of the traditional Chinese medical science " diagnosis and treatment based on an overall analysis of the illness and the patient's condition, reinvigoration "
Shape.Ginseng this people that the present invention selects in dispensing are referred to as " kings of hundred grass ",《Sheng Nong's herbal classic》Record：Ginseng, which has, " to be mended
The five internal organs, soothe the nerves, determine soul, stop palpitate with fear, remove pathogenic factor, happy intelligence development tomorrow " the effect of, " long term usage make light of one's life by commiting suicide macrobiosis " is to consolidate training
Member, the top grade for improving immunity of organisms, fundamentally supplement vigour, strengthen itself resistance, while coordinate and selected with only
The semen armeniacae amarae of cough anti-asthmatic action, warming lung and reducing phlegm walnut kernel, the perilla leaf of ventilating the lung and relieving cough, the natural plant of four kinds of integration of drinking and medicinal herbs of the above
Thing is with that after the exquisite compatibility of green tea, can be effectively improved cough and asthma symptom, and can gradually change cough and asthma person since physically weak hypoimmunity is easy
The situation of recurrent exerbation.
Lung governing qi, lung qi foot just can life it is vigorous, have the function that to adjust internal each internal organs device functional activity, integration of drinking and medicinal herbs
Draft quintessence by daily drinking, cough-relieving facilitaing lung, to play expected purpose.
Embodiment：
Double golden tea of benevolence profit select ginseng (artificial growth), walnut kernel, semen armeniacae amarae, perilla leaf, green tea five tastes natural plants, essence
Heart compatibility, collects the elite of tonic.
Double golden tea of benevolence profit are according to the Q/JST 004S-2016 according to Shaanxi Province's health and Family Planning Committee's approval《Food
Product Enterprise Product Standards》It is processed, wherein each taste dispensing is processed according to following national standard or professional standard respectively：
Ginseng (artificial growth) is according to GB/T19506《Geography symbol product Changbai mountain, Jilin ginseng》With Chinese people's republicanism
The regulation of No. 17 bulletin of the Ministry of Public Health of state 2012 year；Walnut kernel is according to LY/T1992《People's Republic of China's forestry industry standard》
Requirement；Semen armeniacae amarae, perilla leaf according to《Pharmacopoeia of People's Republic of China》The requirement of version first in 2015；Green tea is according to GB/
T14456.1《Green tea Part I basic demand》Requirement after picking, cleaning, done using RXH-140 type heated-air circulation ovens
It is dry 2 it is small when after, through FS-230 types crush unit be ground into 10 mesh, mixed with green tea and vitamin C, reuse DX-
After DK40II automatic packaging machines carry out quantitative separating, aluminium foil bag independent packaging is carried out through FRT-10W types automatic continuous sealing machine
Afterwards, sterilized using the cabinet type sterilizing cabinet of ZTP-910 types, finally carry out mounted box and obtain finished product, after the assay was approved to obtain the final product.
In daily drinking double benevolence profit golden tea time, in order to which draft quintessence in the natural plants of integration of drinking and medicinal herbs in tea bag is abundant
Bring into play, the method for making tea of vexed bubble can be used, tea bag is put into cup with cover, inject after the boiling water of boiling be capped it is vexed
Bubble is drunk again after 15 minutes, and so effect to cough and asthma is more obvious.
The nutrient component meter of double golden tea of benevolence profit
| Project | Per 100g | Nutrient reference value % |
| Energy | 2241kJ | 27% |
| Protein | 6.7g | 11% |
| Fat | 35.8g | 60% |
| Carbohydrate | 47.2g | 16% |
| Sodium | 138mg | 7% |
Claims (3)
- A kind of 1. double golden tea of benevolence profit, it is characterised in that：It is by ginseng (artificial growth), walnut kernel, semen armeniacae amarae, perilla leaf, green Tea, vitamin C, totally 5 taste natural plants and vitamin C.
- A kind of 2. double golden tea of benevolence profit according to claim 1, it is characterised in that：The various composition of wherein one bag (5g) tea Optimum weight is：Ginseng (artificial growth) 0.825g, walnut kernel 0.825g, semen armeniacae amarae 0.825g, perilla leaf 0.825g, green tea 1.65g, vitamin C 0.05g.
- A kind of 3. double golden tea of benevolence profit according to one of claims 1 or 2, it is characterised in that：The value model of various composition Enclosing can control in optimum weight ± 15%, i.e., the weight of the various composition of one bag (5g) tea is ginseng (artificial growth) It is 0.701g-0.949g, walnut kernel 0.701g-0.949g, semen armeniacae amarae 0.701g-0.949g, perilla leaf 0.701g-0.949g, green Tea 1.403g-1.898g, vitamin C 0.043g-0.058g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610932188.2A CN108013170A (en) | 2016-10-31 | 2016-10-31 | Double golden tea of benevolence profit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610932188.2A CN108013170A (en) | 2016-10-31 | 2016-10-31 | Double golden tea of benevolence profit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108013170A true CN108013170A (en) | 2018-05-11 |
Family
ID=62070609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610932188.2A Pending CN108013170A (en) | 2016-10-31 | 2016-10-31 | Double golden tea of benevolence profit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108013170A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108477359A (en) * | 2018-06-01 | 2018-09-04 | 大连大学 | A kind of cucurbit tea-drinking and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105076557A (en) * | 2014-05-09 | 2015-11-25 | 许君寿 | Double-kernel tea |
-
2016
- 2016-10-31 CN CN201610932188.2A patent/CN108013170A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105076557A (en) * | 2014-05-09 | 2015-11-25 | 许君寿 | Double-kernel tea |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108477359A (en) * | 2018-06-01 | 2018-09-04 | 大连大学 | A kind of cucurbit tea-drinking and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (en) | Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof | |
| KR20180037693A (en) | A food composition for preventing and improving lung diseases | |
| CN101926393A (en) | Cordyceps sinensis health-care edible oil | |
| CN104286273A (en) | Application of dendrobium candidum and tea leaf product thereof | |
| CN106359720A (en) | Health protection tea for clearing heat from throat and moistening lung and preparation method thereof | |
| CN104000195B (en) | Clearing lung-heat toxin expelling oral liquid and production method thereof | |
| KR101826737B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
| CN107853517A (en) | A kind of antifatigue Chinese medicinal drink and preparation method thereof of refreshing oneself | |
| CN106692673A (en) | Traditional Chinese lung-heat clearing tea composition and preparation method thereof | |
| CN103656397A (en) | Compound medicine for treating chronic pharyngitis | |
| CN105454944A (en) | Ginseng drink and preparing method | |
| CN106923115A (en) | Plant beverage containing west safflower and its preparation method and application | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN102652575A (en) | Golden-silk jujube health-care drink and producing method thereof | |
| CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
| CN107412345A (en) | A kind of passion fruit seed oil lozenge and preparation method thereof | |
| KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
| CN103520302B (en) | Sea-buckthorn leaf anti-fatigue capsule and preparation method thereof | |
| CN104586977A (en) | Broadleaf holly leaf granule and production method thereof | |
| CN108013170A (en) | Double golden tea of benevolence profit | |
| CN105309923A (en) | Health-care food possessing brain-fortifying intelligence-developing function | |
| CN102091228B (en) | Medicine for treating insomnia and preparation method thereof | |
| KR101476092B1 (en) | Beverage for relieving hangover and manufacturing method thereof | |
| CN113632979A (en) | Four-season health-preserving beverage for men and women and preparation method thereof | |
| CN102067993A (en) | Natural food-therapeutic antitussive apophlegmatic asthma-reducing and lung-nourishing rehabilitation functional beverage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180511 |